Why Rapamycin is the gold standard for longevity interventions - New Video

mTOR Inbititors and Why Rapamycin is the gold standard for longevity interventions.

A new video presentation by University of Washington professor/researcher Dr. Matt Kaeberlein discussing rapamycin and other mTOR inhibitors for the Euro-Geroscience Task Force “Challenges in Developing Geroscience Drug Trials” held March 23, 2022 inToulouse, France.

Click here to watch the video

3 Likes